Doripenem

Related by string. doripenem * * *

Related by context. All words. (Click for frequent words.) 72 Receives Orphan Drug Designation 72 Liprotamase 72 Patients Treated With 71 Meets Primary Endpoint 71 Initiate Clinical Trial 71 Initiates Enrollment 71 Moxifloxacin 71 Fluconazole 71 Files IND 71 Maribavir 70 vapreotide acetate 70 Nitazoxanide 70 Receives Approvable Letter 70 Investigational Treatment 70 Drug Candidate 70 Transdermal Patch 70 Completes Patient Enrollment 70 vinorelbine tartrate 70 Mg Usa 70 Demonstrates Significant 70 Interferon Alpha 70 RECOTHROM R 70 Initiates Phase III 70 Bucindolol 70 Tezampanel 70 Initiates Clinical 69 Successfully Completes Phase 69 Submits NDA 69 Initiates Phase II 69 Bosutinib 69 Vaccine Adjuvant 69 Initiates Clinical Trial 69 investigational pharmacologically unique 69 Mycophenolate Mofetil 69 Anidulafungin 69 Romiplostim 69 Mg Uk 69 Complicated Skin 69 Vitrasert R 69 Glatiramer Acetate 69 Prolongs Survival 69 Aliskiren 69 Zorbtive TM 69 FDA Okays 69 KL4 Surfactant 69 Calcitonin 69 Hsp# Inhibitor 68 oral dual endothelin 68 Investigational Compound 68 NAVISTAR R 68 ADP receptor antagonist 68 Levoleucovorin 68 RNAi Therapeutic 68 Piperacillin 68 FDA APPROVES 68 intranasal formulation 68 targeted antifolate 68 Therapeutic Efficacy 68 Shows Promise Against 68 Immunotherapeutic 68 Eraxis 68 Granted Orphan Drug 68 Announces Tentative Approval 68 MEK Inhibitor 68 Recombinant Human 68 molecular imaging radiopharmaceutical 68 Drug Shows Promise 68 Achieves Primary Endpoint 68 FDA Approvals 68 Novel Antibiotic 68 Single Dose 68 Generic Version 68 Phase IIb Trial 68 Monoclonal Antibody 68 SinuNase TM 68 Temsirolimus 68 Antitumor Activity 68 Neulasta R 68 Significantly Improves 68 Ganciclovir 68 Pulmonary Arterial Hypertension 68 topically applied SEPA 68 Monopril 68 Aflibercept 68 gets USFDA nod 68 SPL# Gel vaginal microbicide 68 Macrolide 68 humanized therapeutic 68 Vitro Activity 68 Presents Positive 68 Pafuramidine 68 Diabetic Neuropathy 68 Investigational eFlow Nebulizer System 68 Itraconazole 68 Kuvan sapropterin dihydrochloride 67 Antiarrhythmic 67 Shows Efficacy 67 Sandimmune 67 candidates Azedra TM 67 Develop Novel 67 Lung Cancer Drug 67 Fluticasone 67 Fabry Disease 67 MTP inhibitor 67 Bazedoxifene 67 Tumor Targeting 67 pregabalin Lyrica 67 Kinase Inhibitor 67 methylnaltrexone bromide 67 Dalbavancin 67 Presents Preclinical Data 67 Launches Generic Version 67 Demonstrates Efficacy 67 Captisol Enabled 67 inhalation powder 67 Naive Patients 67 oral prodrug 67 chimeric monoclonal antibody 67 Teva Provides Update 67 Trodusquemine MSI 67 Bicalutamide 67 Tigecycline 67 acetonide FA 67 MetroGel 67 Study Evaluating 67 HCV Protease Inhibitor 67 R Saizen R 67 Vascugel 67 Ticagrelor 67 small molecule tyrosine 67 meropenem 67 Fast Track Status 67 liposomal formulation 67 mild vasodilator 67 Crofelemer budesonide foam 67 Anti Tumor 67 Proven Effective 67 albiglutide 67 Epratuzumab 67 Proquin XR 67 AFREZZA TM 67 Lubiprostone 67 Tyrosine Kinase Inhibitor 67 Receives Milestone Payment 67 Investigational Oral 67 Talabostat 67 FDA Approves Generic 67 IMiDs ® 67 bucindolol hydrochloride 67 VIVITROL ® 67 Foradil Aerolizer 67 Demonstrates Potential 67 Oral Insulin 67 ankylosing spondylitis psoriatic arthritis 67 oral renin inhibitor 67 Integrase Inhibitor 67 Phase 2b Clinical Trial 67 Crixivan 67 Atripla combines 67 OMNARIS HFA 67 Receives Orphan Drug 67 BioSante Pharmaceuticals Announces 67 Fludara ® 67 Small Molecule 67 Captisol enabled 67 Study Demonstrates 67 COLAZAL R 67 Melphalan 67 Receives Positive Opinion 67 Cefepime 67 PRN FDA Approves 67 Locked Nucleic Acid LNA 67 Sporanox 67 MKC# MKC# PP 67 Files Investigational 67 FDA Clears 66 Ropinirole 66 NeuroSTAT ® 66 Levaquin levofloxacin 66 Zolpimist ™ 66 See CLINICAL PHARMACOLOGY 66 Alexza Staccato 66 ARCALYST R 66 Vascular Grafts 66 Granulocyte Colony Stimulating Factor 66 Mirapexin 66 Cholesterol Lowering Drug 66 Cethromycin 66 Inhalation Aerosol 66 Liposomal 66 Generic Versions 66 ALN HPN 66 Demonstrates Potent 66 FDA Accepts 66 JAK2 Inhibitor 66 candidate deforolimus 66 Begins Dosing 66 Phase III Clinical Trial 66 Desvenlafaxine 66 Altera Nebulizer System 66 Demonstrates Positive 66 Initiates Clinical Trials 66 Personalized Immunotherapy 66 vinca alkaloid 66 XOPENEX R 66 Angiotensin Converting Enzyme 66 Fingolimod 66 Release Tablets 66 Peginterferon 66 pan HDAC inhibitor 66 tetracycline antibiotic 66 pan histone deacetylase 66 humanized monoclonal 66 Known generically 66 Anticancer Agent 66 INSPIRE Trial Phase III 66 Demonstrates Sustained 66 brand ciclesonide HFA 66 Novel Oral 66 orally administered inhibitor 66 CYT# potent vascular disrupting 66 DP VPA 66 Gets FDA Clearance 66 Eculizumab 66 octreotide acetate 66 Fluvastatin 66 targeted radiotherapeutic 66 Myocet 66 Unigene nasal calcitonin 66 Anthracycline 66 Treated Patients 66 proteasome inhibitor 66 thalidomide Thalomid 66 VISICOL R 66 Pruvel TM 66 Therapeutic Vaccine 66 Systemic Delivery 66 essential thrombocythemia ET 66 Denufosol 66 Patients Receiving 66 Tibotec Therapeutics division 66 Mylan Receives Approval 66 Cypher Sirolimus 66 nilotinib Tasigna 66 Announces FDA Clearance 66 Nilotinib 66 ALVESCO ® 66 non nucleoside inhibitor 66 platform HDL Mimetic 66 Gamunex C 66 Atypical Hemolytic Uremic Syndrome 66 Confirms Efficacy 66 Aloprim TM allopurinol sodium 66 Orally administered 66 developing Bicifadine serotonin 66 Intravail ® 66 R bendamustine hydrochloride 66 oral beclomethasone dipropionate 66 topical gel formulation 66 Inflammatory Arthritis 66 Inhalation Solution 66 Initiates Dosing 66 Epidermal Growth Factor Receptor 66 etanercept Enbrel 66 Preclinical Data 66 Parathyroid Hormone 66 Sevelamer 66 Previously Treated 66 Improves Outcomes 66 Treatment Naïve 66 kidney urologic 66 Cx# [002] 66 Aviptadil 66 Romidepsin 66 myelodysplastic myeloproliferative diseases 66 alfa 2a 66 Sustiva efavirenz 66 PEGylated anti 66 Oral Fingolimod 66 Combination REOLYSIN R 66 acyclovir Lauriad R 66 Protease Inhibitor 66 Preclinical Study 66 Metabolic Disorder 66 Gonal f ® 66 dihydrochloride 66 prescription laxative 66 Psoriasis Drug 66 Novel Mechanism 66 cromolyn sodium 66 personalized cellular immunotherapy 66 Immunomodulatory 65 Xeloda ® 65 Bronchodilator 65 Argatroban 65 Novel Therapeutic 65 erlotinib Tarceva ® 65 PKC# 65 broad spectrum cephalosporin 65 Simulect 65 Efficacy Trial 65 Pertuzumab 65 ramipril Altace 65 oxybutynin chloride 65 PEGylated Fab fragment 65 REPRONEX R menotropins 65 ® bortezomib 65 Polymerase Inhibitor 65 Neupogen ® 65 Completes Enrollment 65 Cyclosporin 65 oncolytic virus therapies 65 Lansoprazole 65 Anticancer Drug 65 Initiates Phase 2b 65 non peptidic protease 65 Monoclonal antibody 65 Intravenous Human 65 Gonal f R 65 Rheumatoid Arthritis Drug 65 Peginterferon alfa 2b 65 estrogen receptor antagonist 65 Panzem R 65 M# rationally 65 Ridaforolimus 65 Inflammatory Markers 65 Pegloticase 65 product Fentanyl TAIFUN 65 Ketorolac 65 selective orally bioavailable 65 Clinical Trial Results 65 Vicriviroc 65 Pooled Analysis 65 NDA Submission 65 highly selective inhibitor 65 Maleate 65 evaluating tivozanib 65 tacrolimus capsules 65 Vidaza azacitidine 65 Phase 2a Trial 65 hyaluronidase enzyme 65 Saizen ® 65 BARACLUDE R 65 Hydralazine 65 Antifungal 65 Horizant ™ 65 Epivir R 65 Valopicitabine 65 nucleotide analogue 65 peptidic compound 65 FUSILEV enhances 65 Intravitreal 65 Submits Biologics License Application 65 5 HT3 antagonist 65 Omacetaxine 65 R lenalidomide 65 Aeolus Pharmaceuticals Announces 65 Fondaparinux 65 Warfarin Coumadin 65 oral dihydropyrimidine dehydrogenase DPD 65 Viagra Soft Cialis Soft 65 Clindamycin 65 Factor VIIa 65 nucleoside analog 65 Prodrug 65 Acute Ischemic Stroke 65 MOVIPREP R 65 Investigational Drug 65 Iluvien TM 65 Sumatriptan Succinate 65 Ramelteon 65 Copegus ribavirin 65 Begin Clinical Trials 65 Bendamustine 65 Transdermal Delivery 65 Teriparatide 65 YONDELIS 65 rxRNA 65 Phase III Trial 65 Methylnaltrexone 65 orally disintegrating 65 Demonstrates Statistically Significant 65 Advanced Melanoma 65 beta 1a 65 Reports Preclinical Data 65 Improves Survival 65 Antithrombin 65 levetiracetam Keppra 65 Elotuzumab 65 Aldara ® 65 Ceflatonin R 65 Oral Spray 65 Aurora Kinase 65 Is Well Tolerated 65 Phase 2a Clinical Trial 65 Patient Enrollment 65 Darunavir 65 docetaxel Taxotere ® 65 Actemra tocilizumab 65 Avian Influenza Vaccine 65 Levetiracetam 65 Carbidopa Levodopa 65 adult mesenchymal stem 65 SPRYCEL ® 65 Degarelix 65 Telithromycin 65 delivers fluocinolone acetonide FA 65 Lanthanum Carbonate 65 Linezolid 65 itraconazole Sporanox 65 Paliperidone ER 65 Safinamide 65 Phase 2b Trial 65 Phase IIa Clinical Trial 65 Submits Response 65 Phase IIb Clinical Trial 65 Lenalidomide 65 novel histone deacetylase 65 histone deacetylase HDAC inhibitor 65 Orphan Status 65 Anticancer Activity 65 mesylate 65 Prostate Cancer Vaccine 65 Sapacitabine 65 Dabigatran etexilate 65 lexidronam injection 65 Shows Statistically Significant 65 Geodon ziprasidone 65 Replacement Therapy 65 polymerase inhibitor 65 sublingual formulation 65 RECOTHROM ® 65 BCG refractory carcinoma 65 Lung Cancer Survival 65 Interferon Beta 65 Extended Release 65 Submits IND 65 Wafer polifeprosan 65 PSN# [001] 65 #mg Tablets [002] 65 aripiprazole Abilify 65 Valsartan 65 Transdermal System 65 Dasatinib 65 HCV RNA polymerase 65 Gefitinib 65 Alfacell proprietary ribonuclease 65 combines bupropion 65 denileukin diftitox 65 Candesartan 65 Vildagliptin 65 LymphoStat B TM 65 peripherally acting 65 tamsulosin hydrochloride 65 Fixed Dose Combination 65 fluoroquinolone antibiotic 65 Medoxomil 65 Albuferon TM 65 Azmacort R 65 Pathway Inhibitor 65 Rotavirus Vaccine 65 INTEGRILIN R 65 Submits Supplemental 64 recombinant adeno associated 64 Zemplar 64 Etanercept 64 TNF Tumor Necrosis Factor 64 includes Dideco CarboMedics 64 Lauriad ® 64 Temodar ® 64 Tolvaptan 64 Fosphenytoin 64 Aloxi R 64 Clofarabine 64 Entry Inhibitor 64 Oral Formulation 64 IV Busulfex 64 GW# [003] 64 Aptamer 64 highly purified pasteurized 64 Saizen R 64 Nanoemulsion 64 Low Dose 64 Retinoic Acid 64 5 Fluorouracil 64 Gleevec Glivec 64 ibuprofen Injection 64 Combination Therapy 64 epoetin zeta 64 Campath alemtuzumab 64 Presents Preclinical 64 Receives Complete Response 64 Sipuleucel T 64 Demonstrated Significant 64 Present Preclinical Data 64 Inhalation Powder 64 miconazole Lauriad ® 64 RNAi Therapeutics 64 HuMax TAC 64 Severe Sepsis 64 hereditary emphysema 64 Treating Chronic 64 Viagra Cialis Accutane 64 Patients Treated 64 IMiDs R 64 IMPDH inhibitor 64 ZEVALIN ® 64 Effectively Treats 64 2 methoxyestradiol 64 Anticoagulant 64 rosiglitazone maleate 64 Certolizumab pegol 64 Metastatic Melanoma 64 Potent Antiviral Activity 64 LAB CGRP 64 Ciclesonide 64 IMPACS R 64 nasal calcitonin product 64 cetuximab Erbitux R 64 GlaxoSmithKline Coreg 64 XYOTAX TM 64 Saquinavir 64 Drug Fails 64 SIX RO ROG 64 PNP inhibitor 64 Formoterol 64 immunosuppressant drug 64 Long Term Efficacy 64 candidate Gencaro TM 64 Expanded Indication 64 DUROLANE 64 Aganocide 64 Pazopanib 64 HER2 Positive 64 Conjugate 64 Exjade deferasirox 64 Chronic Hepatitis B 64 Telaprevir VX 64 lucinactant 64 PrevOnco 64 Oropharyngeal Candidiasis 64 serotonin norepinephrine reuptake inhibitor 64 EnteroMedics proprietary neuroblocking technology 64 SinuNase ™ 64 investigational oral inhibitor 64 Epothilones 64 Vidaza R 64 Lyophilized 64 Nucleoside 64 MKC# 64 Chemokine Receptor 64 Significantly Improved 64 NICE Recommends 64 Fulvestrant 64 novel orally inhaled 64 Licenses Novel 64 Locked Nucleic Acid 64 Perindopril 64 Shows Promising 64 Milestone Payment 64 Adult Stem Cell Therapy 64 PEGylated interferon 64 Genentech Rituxan 64 Ozarelix 64 Gout Drug 64 Muraglitazar 64 Immunosuppressant 64 BRILINTA 64 Elagolix 64 Immunomedics Announces 64 Pivotal Study 64 ZOLINZA 64 Orally Active 64 Pivotal Phase III 64 buccal tablets 64 Renal Cell Carcinoma 64 novel oral anticoagulant 64 pioglitazone hydrochloride 64 Plavix clopidogrel bisulfate 64 Losartan Potassium 64 Navelbine ® 64 Myelodysplastic Syndrome MDS 64 Previously Untreated 64 Double Blind Placebo 64 ANDA Filing 64 Imatinib mesylate 64 Nexavar sorafenib tablets 64 Allogeneic 64 BCR ABL inhibitor 64 sorafenib Nexavar 64 candidate TNFerade biologic 64 TRANSDUR ™ 64 Adjuvant Treatment 64 dasatinib Sprycel 64 sapropterin dihydrochloride 64 candidates Azedra 64 demonstrated antitumor activity 64 Inflammatory Diseases 64 PDE4 inhibitor 64 abacavir sulfate lamivudine 64 HDAC Inhibitor 64 vivo validation 64 FS Antihemophilic Factor Recombinant 64 ciprofloxacin hydrochloride 64 Losartan 64 Evoclin R 64 Crit Rev 64 Aztreonam 64 Gel repository corticotropin injection 64 Oral Calcitonin 64 Combivir Kivexa 64 arsenic trioxide injection 64 Receives CE Marking 64 Diovan Exforge Tekturna Zelnorm 64 TELINTRA R 64 Squalamine 64 Orapred ODT 64 Nutra Pharma wholly owned 64 IMiDs ® compound 64 Therapeutic Competitors Report 64 Tocilizumab 64 Gastric Cancer 64 MKC# MT 64 Kidney Transplant Patients 64 receptor tyrosine kinase inhibitor 64 Oral Suspension USP 64 cidofovir 64 Initiate Phase 64 Chronic Sinusitis 64 Febuxostat 64 successfully commercialize Iluvien 64 Ecallantide 64 outlicensed 64 solifenacin succinate 64 PecFent 64 Pirfenidone 64 Clinical Trial Evaluating 64 GTC recombinant human 64 Montelukast 64 Indomethacin 64 Renal Impairment 64 Delafloxacin 64 Dexilant 64 IMA# 64 SUPPRELIN R LA 64 First Patient Dosed 64 Entecavir 64 Medidur ™ FA 64 PROCRIT R 64 thetreatment 64 Luteinizing Hormone Releasing Hormone 64 ceftazidime 64 Actonel risedronate 64 Recombinant Protein 64 Treatment Reduces 64 Study Showed 64 Budesonide 64 Boniva ibandronate 64 Alkeran 64 apomorphine hydrochloride 64 refractory chronic lymphocytic 64 Receives Fast Track 64 Synthetic Peptide 64 developing Zerenex ferric 64 Interferon alfa 64 Levocetirizine 64 Miconazole 64 sorafenib tablets 64 Lixisenatide 64 Levofloxacin 64 NASH Huntington 64 nizatidine 64 Entocort 64 metformin HCl 64 Indaflex TM 64 Dementia Related Psychosis 64 Daclizumab 64 Respiratory Virus 64 Roche Boniva 64 Filgrastim 64 Tesetaxel 64 Central Venous Catheters 64 XL# anticancer compounds 64 Hepatocellular Carcinoma 64 hypereosinophilic syndrome 63 RAPAFLO 63 Voreloxin 63 Trial Evaluating 63 Golimumab 63 Proventil 63 lipoglycopeptide 63 Etoposide 63 adalimumab Humira 63 Azacitidine 63 IND Application 63 metaglidasen 63 SUTENT ® 63 Hydrochlorothiazide Tablets 63 Vaccine Protects Against 63 Adenoscan R 63 small molecule glucokinase 63 Thiazolidinediones 63 Receives Tentative Approval 63 synthetic retinoid 63 Novel Antibody 63 topically administered 63 doxercalciferol 63 Therapeutic Competitors Companies 63 long acting muscarinic 63 label Lipofen R 63 Maven Semantic 63 Vfend 63 Antitumor 63 Treatment Resistant 63 Abbokinase 63 selective modulator 63 A1PI 63 Receptor Agonist 63 Generic Version Of 63 hormone LHRH antagonist 63 Genotyping Test 63 acting muscarinic antagonist 63 RELOVAIR ™ 63 Prolastin A1PI 63 siRNA Delivery 63 lansoprazole Prevacid 63 epoetin alpha 63 Telbivudine 63 PHX# 63 SYCREST 63 Eluting Coronary Stent System 63 Suppositories 63 Empatic ™ 63 Tofacitinib 63 BYETTA ® 63 Lymphocytic 63 Auto Injector 63 Tacrolimus 63 HP Acthar R 63 Perforomist ™ Inhalation Solution 63 Civacir 63 Qutenza TM 63 AAG geldanamycin analog 63 Interferon Gamma 63 Aloxi ® 63 ATRA IV 63 INTEGRILIN ® 63 Intravenous Formulation 63 Treatment Shows Promise 63 Advicor R 63 proprietary polysaccharide 63 Dapagliflozin 63 xanthine oxidase inhibitor 63 Successfully Treated 63 Zalypsis 63 Deferiprone 63 intravesical infusion therapy 63 Receives SFDA Approval 63 HIV treatments Reyataz 63 Carvedilol 63 PERLANE 63 Oxybutynin 63 Valganciclovir 63 ® lenalidomide 63 Racivir 63 Chronic Hepatitis C 63 glatiramer 63 Decitabine 63 histone deacetylase inhibitor 63 markets HP Acthar 63 Lenocta 63 Non Invasive Treatment 63 Cancidas 63 olanzapine Zyprexa 63 TNF alpha selectively neutralizing 63 RAPTIVA 63 Sustained Release 63 orally disintegrating formulation 63 Orally Disintegrating Tablets 63 OMAPRO ™ 63 equine osteoarthritis 63 PORxin TM 63 Proves Effective 63 Elvitegravir 63 Commonly prescribed 63 metformin hydrochloride 63 eFlow R 63 Presents Positive Preclinical 63 Pradaxa ® 63 Thiovir 63 Positive Opinion 63 LymphoStat B belimumab 63 protein tyrosine phosphatase 1B 63 Erlotinib 63 small molecule thrombopoietin 63 Topical Gel 63 Cathepsin S 63 administered intranasally 63 Mouse Model 63 RhuDex ® 63 prescribed proton pump 63 Benazepril 63 Phase III Trials 63 antiarrhythmic agent 63 adenosine injection 63 Zegerid OTC 63 Etravirine 63 Nebulized 63 STELARA TM 63 Hectorol ® 63 evaluating picoplatin 63 Relapsing Multiple Sclerosis 63 Well Tolerated 63 JAK2 inhibitor 63 Antibody Drug Conjugate 63 Thrombin 63 Fungal Infections 63 Pravastatin 63 Anti Nausea 63 rasagiline tablets 63 novel synthetic PEGylated 63 abacavir Ziagen 63 Olaparib 63 acadesine 63 treat benign prostatic 63 Mimetics 63 Nabi HB ® 63 Newly Diagnosed Multiple Myeloma 63 Azathioprine 63 Reclast zoledronic acid 63 Heart Transplant Recipients 63 First Patient Enrolled 63 Lopinavir 63 Antibacterials 63 HCV NS5B polymerase 63 radezolid 63 lead molecular radiotherapeutic 63 Terbinafine 63 Hypertensive Patients 63 Gilead Viread 63 Technosphere ® 63 imatinib Gleevec ® 63 LEUKINE 63 inhaled formulations 63 IONSYS TM 63 platelet aggregation inhibitor 63 II Clinical Trial 63 Amlodipine Besylate 63 phase III isavuconazole 63 investigational antiplatelet agent 63 Xcytrin R 63 Reduces Mortality 63 ThermoDox R 63 small molecule Hedgehog 63 R bisoprolol Euthyrox 63 Biolimus A9 63 Therapy Improves 63 TNF Blockers 63 Arthritis Drug 63 Dual Opioid TM 63 P#X# antagonist 63 Multiple Sclerosis Rheumatoid Arthritis 63 Lung Infections 63 Novel Compound 63 ProEthic Pharmaceuticals 63 Prograf ® 63 orally inhaled 63 Therapeutic Antibody 63 Prospective Randomized 63 Clolar ® 63 Anti Tumor Activity 63 Adjunctive Therapy 63 Survival Benefit 63 Onconase 63 oral probiotic 63 pioglitazone HCl 63 Dyloject TM 63 Epoprostenol 63 MERREM 63 Capoten 63 Pemetrexed 63 treat male hypogonadism 63 Molecular Diagnostic 63 vancomycin hydrochloride 63 Bertek Pharmaceuticals 63 Commences Phase 63 Retacrit 63 fluvoxamine maleate 63 Oracea TM 63 Remicade infliximab 63 Improved Survival 63 Xyzal R 63 Significantly Reduces 63 virus HCV protease inhibitor 63 Dacogen decitabine 63 CTAP# Capsules 63 Cholesterol Lowering 63 Oracea ® 63 PROMUS R 63 Slows Progression 63 Prodarsan R 63 buccal spray 63 include Phenoptin TM 63 fosbretabulin 63 #mg #mg #mg #mg [002] 63 Liver Tumors 63 Investigational Agent 63 Hydrochlorothiazide 63 gefitinib Iressa 63 Finacea 63 Interferon alpha 63 Tipranavir 63 OvaRex R 63 Ovitrelle R Serostim 63 CYP#A# CYP#D# 63 TRISENOX R 63 Gemzar ® 63 XYZAL R 63 Pegylated 63 gabapentin Neurontin 63 rHuPH# recombinant human 63 Human Monoclonal Antibody 63 Antiviral Therapy 63 Test Detects 63 Mitoxantrone 63 Ixabepilone 63 SinoFresh TM 63 orally disintegrating tablets 63 sitagliptin metformin 63 tazobactam 63 Adagen ® 63 Zileuton 63 oral rivaroxaban 63 somatostatin analogue 63 Albugon 63 either acutely decompensated 63 miRview ™ squamous 63 ARRY # 63 Abatacept 63 oral salmon calcitonin 63 Xanafide 63 Diskus 63 Dose Escalation 63 Vaccine Adjuvants 63 Indacaterol 63 Ustekinumab 63 Cleviprex TM clevidipine 63 zoledronate 63 Vancocin R 63 Osteoporosis Treatment 63 Tumor Response 63 Vancocin ® 63 Receive Milestone Payment 63 Boceprevir 63 Nexavar ® 63 GTC recombinant form 63 Gemzar gemcitabine 63 Loceryl ® 63 dihydroergotamine 63 Adefovir 63 Phase 2b Study 63 Zenpep 63 granisetron formulated 63 JAK Inhibitor 63 Campto 63 Collaborators Publish 63 therapeutic monoclonal antibody 63 investigational humanized monoclonal antibody 63 piperacillin 63 CCR9 antagonist 63 Fixed Dose 63 Pivotal Clinical Trial 63 Hospital Acquired Pneumonia 63 agonistic human 63 ORENCIA ® 63 benzoic acid hyoscyamine sulfate 62 Rivaroxaban 62 fluoroquinolone class 62 brivanib 62 Relapsed Refractory 62 Pharmacokinetics PK 62 novel emulsion formulation 62 Investigational eFlow 62 Cardiotoxicity 62 echinocandin 62 Haemophilus b Conjugate 62 ACE Inhibitors 62 novel VDA molecule 62 Tuberculosis Vaccine 62 Isavuconazole 62 lamotrigine Lamictal 62 tenofovir Viread 62 Tenofovir DF 62 biologic antibody 62 Systemic Sclerosis 62 Advanced Prostate Cancer 62 InfaCare Pharmaceutical Corporation 62 Plaquenil 62 Microplasmin

Back to home page